Singapore scientists track genetic changes to speed up testing for coronavirus vaccines

Currently, there are no medicines or preventive vaccines targeting the virus, with most patients receiving only supportive care.

Reuters March 25, 2020 14:50:50 IST
Singapore scientists track genetic changes to speed up testing for coronavirus vaccines

Scientists in Singapore say they have developed a way to track genetic changes that speeds testing of vaccines against a coronavirus that has killed more than 16,000 people worldwide.

The scientists, at the city-state’s Duke-NUS Medical School, say their technique needs just days to evaluate potential vaccines provided by Arcturus Therapeutics, an American biotech firm the school has partnered with for the trials.

That timeframe compares with the months usually required for testing based on human responses.

Singapore scientists track genetic changes to speed up testing for coronavirus vaccines

Currently there are no treatments or preventive vaccines that target the virus . Image by Наркологическая Клиника from Pixabay.

“You can know from the way the genes change - what genes are turned on, what are turned off,” said Ooi Eng Eong, deputy director of the school’s emerging infectious diseases program.

Swift assessment of such changes triggered by a vaccine allows the scientists to determine its effectiveness and side effects, instead of relying solely on responses from humans who receive it, he added.

Currently, there are no approved medicines or preventive vaccines targeting the virus, with most patients receiving only supportive care, such as help with their breathing. Experts have said getting a vaccine ready could take a year or more.

Ooi said he planned to start testing vaccines in mice in about a week, with human trials expected in the second half of the year.

Pharmaceutical firms and researchers around the globe are racing to develop vaccines and treatments for the virus, which has infected more than 377,000 people.

These efforts include Gilead Sciences Inc’s experimental antiviral drug remdesivir and a plasma-derived therapy from Japan’s Takeda Pharmaceutical Co.

In a key step towards developing diagnostic methods, the Duke-NUS scientists helped culture the virus in late January, days after Singapore confirmed its first infection. That made it the third country, outside China, to culture the virus.

Another first was a test to detect virus antibodies even in those who had already recovered, crucial in containment efforts that have won global praise for Singapore.

From discovery to licensing, vaccine development in the past could take more than 10 years, but Ooi said science can now offer a much faster response.

“Everyone is racing ahead, but we are kind of writing the playbook as the game is being played,” he added.

Updated Date:

also read

Newer Omicron subvariants escape immunity provided by vaccination, previous infection: Study
India

Newer Omicron subvariants escape immunity provided by vaccination, previous infection: Study

The study provides the immunologic context for current surges among populations with high rates of vaccinations and previous infection

India sees 29% rise in new COVID-19 cases; 18,819 test positive, 39 dead in last 24 hours
India

India sees 29% rise in new COVID-19 cases; 18,819 test positive, 39 dead in last 24 hours

The number of COVID-19 active cases has surpassed the one lakh mark again after 122 days. The country now has 1,04,555 active cases of coronavirus

India logs 17,070 new COVID-19 cases, 23 deaths in last 24 hours; active cases increase to 1,07,189
India

India logs 17,070 new COVID-19 cases, 23 deaths in last 24 hours; active cases increase to 1,07,189

The health ministry said that 14,413 patients recuperated from COVID-19 in the last 24 hours, increasing the total recoveries to 4,28,36,906